Protagonist Therapeutics, Inc. (PTGX)
89.11
+0.55
(+0.62%)
USD |
NASDAQ |
Dec 10, 09:32
Protagonist Therapeutics Research and Development Expense (TTM): 147.84M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Johnson & Johnson | 15.77B |
| ADMA Biologics, Inc. | 3.776M |
| Regeneron Pharmaceuticals, Inc. | 5.097B |
| Vanda Pharmaceuticals, Inc. | 100.10M |
| Bristol Myers Squibb Co. | 9.719B |